RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
RGDX was delisted on the 2nd of July, 2015.
18 hedge funds and large institutions have $20.8M invested in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in 2013 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
29% more funds holding
Funds holding: 14 → 18 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
51% less capital invested
Capital invested by funds: $42M → $20.8M (-$21.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$291K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$111K |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$54.5K |
| 4 |
Goldman Sachs
New York
|
+$34.3K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$7.71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sophrosyne Capital
New York
|
-$1.08M |
| 2 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
-$1.04M |
| 3 |
NRCM
Northern Right Capital Management
Darien,
Connecticut
|
-$363K |
| 4 |
AIG
American International Group
New York
|
-$2.22K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
RGDX Hedge Fund Activity: Q4 2013 in Review
18 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) for Q4 2013, worth a combined $20.8M — down 51% from $42M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new RGDX positions and 3 closed out — a net gain of 4 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $291K. The largest seller was Sophrosyne Capital, exiting entirely with an estimated $1.08M sold.
- 18 institutional investors held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) as of Q4 2013, up from 14 in Q3 2013.
- Funds reported $20.8M of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) stock for Q4 2013, down 51% quarter-over-quarter.
- 7 funds opened new RESPONSE GENETICS, INC COMMON SHS (DELAWARE) positions in Q4 2013 and 3 closed out, a net change of +4 holders.
- The largest RESPONSE GENETICS, INC COMMON SHS (DELAWARE) buyer in Q4 2013 was Vanguard Group, an estimated $291K added.
- The largest RESPONSE GENETICS, INC COMMON SHS (DELAWARE) seller in Q4 2013 was Sophrosyne Capital, an estimated $1.08M sold.
Based on aggregated 13F filings for Q4 2013.